Print

Startup Developing Cancer Diagnostics, Predicant Biosciences Gets $10 Million; Tony Shuber Joins Company As Chief Technology Officer  
12/18/2006 12:02:08 PM

LEXINGTON -- Six-month-old Predictive Biosciences, which is using technology licensed from Children's Hospital Boston to create noninvasive cancer diagnosis products, received $10 million in first-round funding from co-lead investors Highland Capital Partners in Lexington and IDG Ventures Boston.

>>> Discuss This Story


//-->